Conivaptan and its role in the treatment of hyponatremia
Jalal K Ghali,1 Jareer O Farah,2 Suleiman Daifallah,3 Hassan A Zabalawi,4 Hammam D Zmily51Detroit Medical Center, Detroit, MI, USA; 2Wayne State University/Detroit Medical Center, Detroit, MI, USA; 3John D Dingell VA Medical Center, Detroit, MI, USA; 4,5Wayne State University/Detroit Medical Center,...
Main Authors: | Jalal K Ghali, Jareer O Farah, Suleiman Daifallah, et al |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2009-10-01
|
Series: | Drug Design, Development and Therapy |
Online Access: | http://www.dovepress.com/conivaptan-and-its-role-in-the-treatment-of-hyponatremia-a3638 |
Similar Items
-
Conivaptan: a step forward in the treatment of hyponatremia?
by: Su Su Hline, et al.
Published: (2008-04-01) -
Tolvaptan, hyponatremia, and heart failure
by: Zmily HD, et al.
Published: (2011-03-01) -
New Topics in Vasopressin Receptors and Approach to Novel Drugs: Research and Development of Conivaptan Hydrochloride (YM087), a Drug for the Treatment of Hyponatremia
by: Yukinori Arai, et al.
Published: (2009-01-01) -
Efficacy of vaptans for correction of postoperative hyponatremia: A comparison between single intravenous bolus conivaptan vs oral tolvaptan
by: Sunil Rajan, et al.
Published: (2018-01-01) -
The effect of intravenous conivaptan on intraocular pressure
by: Saritha Valsala Krishnankutty, et al.
Published: (2016-01-01)